SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-098197
Filing Date
2024-09-09
Accepted
2024-09-09 17:00:33
Documents
14
Period of Report
2024-09-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2423592d2_8k.htm   iXBRL 8-K 26036
2 EXHIBIT 3.1 tm2423592d2_ex3-1.htm EX-3.1 10302
  Complete submission text file 0001104659-24-098197.txt   216547

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snpx-20240903.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20240903_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20240903_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2423592d2_8k_htm.xml XML 3919
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 241287879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)